Mayor & City Cncl. of Balt v. McKesson Corp.

Plain English (For Everyone)

Imagine a city suing a company that delivered a product, saying the deliveries themselves caused a big problem like the opioid crisis. This court said that just delivering the product, even if it's later misused, isn't enough to hold the delivery company responsible for the city's problems. The city needed to show more than just the deliveries happened; they had to prove the company's actions directly created a public nuisance.

For Legal Practitioners

The court affirmed dismissal of the city's public nuisance claims against McKesson, holding that the complaint failed to adequately plead that the distributor's actions constituted a public nuisance under Maryland law. Crucially, the court distinguished between the harms caused by the *use* of opioids and the *distribution* of those opioids, finding the former did not automatically translate to liability for the latter without more specific allegations of the distributor's direct contribution to the nuisance. This reinforces the need for plaintiffs to plead specific conduct by distributors that directly creates or exacerbates a public nuisance, rather than relying on the mere fact of distribution.

For Law Students

This case tests the elements of a public nuisance claim against a drug distributor. The court focused on whether the plaintiff sufficiently alleged that McKesson's *distribution* practices, rather than the *end-use* of the drugs, created a public nuisance. This ruling highlights the distinction between indirect harm from product distribution and direct creation of a nuisance, emphasizing the need for specific pleading regarding the distributor's role in exacerbating the public harm. It fits within tort law, specifically nuisance and proximate cause doctrines.

Newsroom Summary

Baltimore's lawsuit against opioid distributor McKesson has been dismissed, with a court ruling that simply distributing prescription drugs doesn't automatically make a company liable for the opioid crisis. The decision clarifies that cities must prove distributors actively contributed to a public nuisance, not just that the drugs were distributed.

Standard of Review

The standard of review is de novo. This means the appellate court reviews the legal issues anew, without deference to the lower court's decision. It applies here because the appeal concerns the interpretation of a statute, which is a question of law.

Procedural Posture

This case reached the Maryland Court of Appeals on a certified question from the United States District Court for the District of Maryland. The District Court had denied a motion to dismiss filed by the Mayor and City Council of Baltimore, and the City appealed that denial. The core of the dispute is whether the City's tax on McKesson Corporation is preempted by federal law.

Burden of Proof

The burden of proof is on the party seeking to invalidate the tax, which is McKesson Corporation. They must demonstrate that the City's tax is preempted by federal law.

Statutory References

Key Legal Definitions

Rule Statements

A tax is discriminatory if it singles out a particular entity for taxation or imposes a tax that is disproportionately burdensome on a particular entity.

The purpose of § 40116(b) is to prevent states and localities from imposing discriminatory taxes on air carriers and their property.

Scenario: You are a pharmacy technician who correctly dispenses a prescription for a pain medication. Later, the patient misuses the medication, leading to addiction and contributing to a local opioid crisis. The city sues the pharmacy and the distributor for creating a public nuisance.

Your Rights: You have the right to expect that your actions, when following legal dispensing procedures, will not automatically make you or your employer liable for the end-user's misuse of a legally prescribed medication. The distributor also has the right to not be held liable for public nuisance simply because they distributed a product that was later misused.

What To Do: If you are involved in dispensing or distributing medications, ensure all procedures are followed strictly according to law and professional guidelines. If a lawsuit arises, consult with legal counsel immediately to understand the specific claims and defenses available, particularly regarding the distinction between lawful distribution and the creation of a public nuisance.

Is it legal for a pharmaceutical distributor to be sued by a city for contributing to the opioid crisis simply because they distributed the drugs?

Depends. This ruling suggests it is not legal to hold a distributor liable for public nuisance solely based on the fact of distribution. The city must prove the distributor's specific actions directly created or exacerbated the public nuisance, not just that the drugs passed through their hands.

This ruling applies specifically to Maryland law regarding public nuisance claims against distributors.

For Pharmaceutical Distributors

This ruling provides some clarity and potential protection for pharmaceutical distributors against broad public nuisance claims. It emphasizes that liability requires specific allegations of conduct that directly creates or worsens a public nuisance, rather than simply distributing a product that is later misused.

For Municipalities and Public Health Officials

Cities and other municipalities seeking to hold distributors liable for the opioid crisis must now carefully craft their public nuisance claims. They need to provide specific evidence of how the distributor's actions, beyond mere distribution, directly contributed to the public nuisance, which may be a higher pleading standard.

Q: What is Mayor & City Cncl. of Balt v. McKesson Corp. about?

Mayor & City Cncl. of Balt v. McKesson Corp. is a case decided by Maryland Court of Appeals on April 24, 2026.

Q: What court decided Mayor & City Cncl. of Balt v. McKesson Corp.?

Mayor & City Cncl. of Balt v. McKesson Corp. was decided by the Maryland Court of Appeals, which is part of the MD state court system. This is a state supreme court.

Q: When was Mayor & City Cncl. of Balt v. McKesson Corp. decided?

Mayor & City Cncl. of Balt v. McKesson Corp. was decided on April 24, 2026.

Q: What was the docket number in Mayor & City Cncl. of Balt v. McKesson Corp.?

The docket number for Mayor & City Cncl. of Balt v. McKesson Corp. is 354pet/25. This identifier is used to track the case through the court system.

Q: What is the citation for Mayor & City Cncl. of Balt v. McKesson Corp.?

The citation for Mayor & City Cncl. of Balt v. McKesson Corp. is . Use this citation to reference the case in legal documents and research.

Q: Is Mayor & City Cncl. of Balt v. McKesson Corp. published?

Mayor & City Cncl. of Balt v. McKesson Corp. is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What was the ruling in Mayor & City Cncl. of Balt v. McKesson Corp.?

The court ruled in favor of the defendant in Mayor & City Cncl. of Balt v. McKesson Corp.. Key holdings: The court held that a public nuisance claim requires a showing of unreasonable interference with a right common to the general public, and that the city failed to adequately plead how McKesson's distribution practices constituted such an interference.; The court affirmed the dismissal of the public nuisance claim, finding that the city's allegations did not establish that McKesson's conduct was the proximate cause of the public nuisance alleged.; The court clarified that while drug distributors can be liable for public nuisance, the specific allegations must demonstrate a direct link between the distributor's actions and the harm to the public, not just the availability of drugs.; The court found that the city's complaint did not sufficiently allege that McKesson engaged in deceptive marketing or actively promoted the misuse of opioids, which are often key elements in public nuisance claims against pharmaceutical entities.; The court rejected the city's argument that the sheer volume of opioid distribution by McKesson, without more, was sufficient to establish a public nuisance claim..

Q: Why is Mayor & City Cncl. of Balt v. McKesson Corp. important?

Mayor & City Cncl. of Balt v. McKesson Corp. has an impact score of 60/100, indicating significant legal impact. This decision provides clarity on the pleading standards for public nuisance claims against pharmaceutical distributors in the context of the opioid crisis. It signals that merely distributing large quantities of opioids may not be enough to establish liability, and plaintiffs must demonstrate a more direct link between the distributor's actions and the resulting public harm.

Q: What precedent does Mayor & City Cncl. of Balt v. McKesson Corp. set?

Mayor & City Cncl. of Balt v. McKesson Corp. established the following key holdings: (1) The court held that a public nuisance claim requires a showing of unreasonable interference with a right common to the general public, and that the city failed to adequately plead how McKesson's distribution practices constituted such an interference. (2) The court affirmed the dismissal of the public nuisance claim, finding that the city's allegations did not establish that McKesson's conduct was the proximate cause of the public nuisance alleged. (3) The court clarified that while drug distributors can be liable for public nuisance, the specific allegations must demonstrate a direct link between the distributor's actions and the harm to the public, not just the availability of drugs. (4) The court found that the city's complaint did not sufficiently allege that McKesson engaged in deceptive marketing or actively promoted the misuse of opioids, which are often key elements in public nuisance claims against pharmaceutical entities. (5) The court rejected the city's argument that the sheer volume of opioid distribution by McKesson, without more, was sufficient to establish a public nuisance claim.

Q: What are the key holdings in Mayor & City Cncl. of Balt v. McKesson Corp.?

1. The court held that a public nuisance claim requires a showing of unreasonable interference with a right common to the general public, and that the city failed to adequately plead how McKesson's distribution practices constituted such an interference. 2. The court affirmed the dismissal of the public nuisance claim, finding that the city's allegations did not establish that McKesson's conduct was the proximate cause of the public nuisance alleged. 3. The court clarified that while drug distributors can be liable for public nuisance, the specific allegations must demonstrate a direct link between the distributor's actions and the harm to the public, not just the availability of drugs. 4. The court found that the city's complaint did not sufficiently allege that McKesson engaged in deceptive marketing or actively promoted the misuse of opioids, which are often key elements in public nuisance claims against pharmaceutical entities. 5. The court rejected the city's argument that the sheer volume of opioid distribution by McKesson, without more, was sufficient to establish a public nuisance claim.

Q: How does Mayor & City Cncl. of Balt v. McKesson Corp. affect me?

This decision provides clarity on the pleading standards for public nuisance claims against pharmaceutical distributors in the context of the opioid crisis. It signals that merely distributing large quantities of opioids may not be enough to establish liability, and plaintiffs must demonstrate a more direct link between the distributor's actions and the resulting public harm. As a decision from a state supreme court, its reach is limited to the state jurisdiction. This case is moderate in legal complexity to understand.

Q: Can Mayor & City Cncl. of Balt v. McKesson Corp. be appealed?

Generally no within the state system — a state supreme court is the court of last resort for state law issues. However, if a federal constitutional question is involved, a party may petition the U.S. Supreme Court for review.

Q: What cases are related to Mayor & City Cncl. of Balt v. McKesson Corp.?

Precedent cases cited or related to Mayor & City Cncl. of Balt v. McKesson Corp.: Mayor & City Council of Balt. v. Purdue Pharma L.P., 450 Md. 138 (2016); Restatement (Second) of Torts § 821B.

Q: What specific allegations are needed to successfully plead a public nuisance claim against a drug distributor?

A plaintiff must allege facts showing unreasonable interference with a public right and that the defendant's conduct was the proximate cause of that interference. This often requires demonstrating deceptive marketing, promotion of misuse, or other direct actions contributing to the public harm, beyond mere distribution.

Q: Does the volume of drug distribution alone constitute a public nuisance?

No, the court indicated that the volume of distribution, without more, is insufficient to establish a public nuisance. The plaintiff must demonstrate how that distribution unreasonably interfered with a public right and was the proximate cause of the harm.

Q: How does this ruling impact other opioid litigation against distributors?

This ruling reinforces the need for plaintiffs to carefully plead specific facts demonstrating causation and unreasonable interference with public rights, rather than relying solely on the widespread availability of opioids as the basis for a public nuisance claim against distributors.